×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [4]
THE STATE KEY LA... [3]
Faculty of Healt... [2]
Authors
LEUNG CHUNG HANG [2]
WANG RUIBING [1]
OUYANG DEFANG [1]
Document Type
Journal article [5]
Book chapter [1]
Review article [1]
Date Issued
2022 [1]
2020 [2]
2019 [2]
2015 [1]
2013 [1]
Language
英語English [6]
Source Publication
ACS Applied Bio ... [2]
Cell Journal [1]
Frontiers in Com... [1]
Molecules [1]
PHARMACEUTICS [1]
Toxicology and A... [1]
More...
Indexed By
SCIE [4]
ESCI [2]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-7 of 7
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions
Journal article
Li, Xiaocui, Ou, Xiaowen, Ni, Jiadong, Xu, Yihong, Zuo, Huilin, Fu, Yu, Yang, Caihua, Zhao, Zhongxiang, Li, Na, Zhou, Hua, Zhang, Rong, Liu, Zhongqiu, Fu, Ling, Zhu, Lijun. Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions[J]. Toxicology and Applied Pharmacology, 2022, 445.
Authors:
Li, Xiaocui
;
Ou, Xiaowen
;
Ni, Jiadong
;
Xu, Yihong
;
Zuo, Huilin
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
3.3
/
3.6
|
Submit date:2023/01/30
Adverse Reaction
Bulleyaconitine a
Cytochrome P450 Enzymes
Drug-drug Interactions
Human Liver Microsomes
Metabolism
Oral Colon-Targeted Konjac Glucomannan Hydrogel Constructed through Noncovalent Cross-Linking by Cucurbit[8]uril for Ulcerative Colitis Therapy
Journal article
Ding,Yuan Fu, Sun,Tianlei, Li,Shengke, Huang,Qiaoxian, Yue,Ludan, Zhu,Liangkui, Wang,Ruibing. Oral Colon-Targeted Konjac Glucomannan Hydrogel Constructed through Noncovalent Cross-Linking by Cucurbit[8]uril for Ulcerative Colitis Therapy[J]. ACS Applied Bio Materials, 2020, 3(1), 10-19.
Authors:
Ding,Yuan Fu
;
Sun,Tianlei
;
Li,Shengke
;
Huang,Qiaoxian
;
Yue,Ludan
; et al.
Favorite
|
TC[WOS]:
54
TC[Scopus]:
57
IF:
4.6
/
4.4
|
Submit date:2021/03/02
Colitis
Controlled Drug Release
Cucurbituril
Host-guest Interactions
Konjac Glucomannan
Oral Colon-Targeted Konjac Glucomannan Hydrogel Constructed through Noncovalent Crosslinking by Cucurbit[8]uril for Ulcerative Colitis Therapy
Journal article
Ding, Y. F., Sun, T., Li, S., Huang, Q., Yue, L., Zhu, L., Wang, R.. Oral Colon-Targeted Konjac Glucomannan Hydrogel Constructed through Noncovalent Crosslinking by Cucurbit[8]uril for Ulcerative Colitis Therapy[J]. ACS Applied Bio Materials, 2020, 3(1), 10-19.
Authors:
Ding, Y. F.
;
Sun, T.
;
Li, S.
;
Huang, Q.
;
Yue, L.
; et al.
Favorite
|
TC[WOS]:
54
TC[Scopus]:
57
IF:
4.6
/
4.4
|
Submit date:2022/07/27
Colitis
Controlled Drug Release
Cucurbituril
Host-guest Interactions
Konjac Glucomannan
Mimicking strategy for protein-protein interaction inhibitor discovery by virtual screening
Review article
2019
Authors:
Wu,Ke Jia
;
Lei,Pui Man
;
Liu,Hao
;
Wu,Chun
;
Leung,Chung Hang
; et al.
Favorite
|
TC[WOS]:
17
TC[Scopus]:
23
IF:
4.2
/
4.6
|
Submit date:2021/03/01
Protein-protein Interactions
Virtual Screening
Mimetics
Drug Discovery
Molecular Interactions for the Curcumin-Polymer Complex with Enhanced Anti-Inflammatory Effects
Journal article
Yan He, Hongfei Liu, Wangqing Bian, Yue Liu, Xinyang Liu, Shijing Ma, Xi Zheng, Zhiyun Du, Kun Zhang, Defang Ouyang. Molecular Interactions for the Curcumin-Polymer Complex with Enhanced Anti-Inflammatory Effects[J]. PHARMACEUTICS, 2019, 11(9).
Authors:
Yan He
;
Hongfei Liu
;
Wangqing Bian
;
Yue Liu
;
Xinyang Liu
; et al.
Favorite
|
TC[WOS]:
44
TC[Scopus]:
51
IF:
4.9
/
5.5
|
Submit date:2020/03/25
Curcumin
Polyvinylpyrrolidone (Pvp)
Solid Dispersions
Molecular Modeling
Drug-polymer Interactions
Recent Advances in the Discovery and Development of Protein-Protein Interaction Modulators by Virtual Screening
Book chapter
出自: Frontiers in Computational Chemistry:Elsevier Inc., 2015, 页码:121-157
Authors:
Ma D.-L.
;
Liu L.-J.
;
Lin S.
;
Wang M.
;
Chan D.S.-H.
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2018/11/06
Computer-aided Drug Discovery
Drug Development
Molecular Docking
Protein-protein Interactions
Virtual Screening
Impact of fixed-dose combination of germacrone, curdione, and furanodiene on breast cancer cell proliferation
Journal article
Kong Q., Sun F., Chen X.. Impact of fixed-dose combination of germacrone, curdione, and furanodiene on breast cancer cell proliferation[J]. Cell Journal, 2013, 15(2), 160-165.
Authors:
Kong Q.
;
Sun F.
;
Chen X.
Favorite
|
TC[WOS]:
23
TC[Scopus]:
28
IF:
1.7
/
1.9
|
Submit date:2018/12/28
Proliferation
Breast Cancer
Fixed-dose-combination
Intra-herbal Drug Interactions
Chinese Medicine